Sabby Management, LLC Bio Line Rx Ltd. Transaction History

Sabby Management, LLC

  • $130,000
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$1.23 - $2.45 $258,300 - $514,500
210,000 New
210,000 $382,000
Q4 2022

Feb 14, 2023
SELL
$0.57 - $0.95 $730,805 - $1.22 Million
-1,282,115 Reduced 42.26%
1,751,992 $1.03 Million
Q3 2022

Nov 14, 2022
BUY
$0.88 - $1.91 $2.67 Million - $5.8 Million
3,034,107 New
3,034,107 $2.81 Million

Others Institutions Holding BLRX

# of Institutions
37
Shares Held
3.3M
Call Options Held
46.5K
Put Options Held
6.3K
View Full List

About BioLineRx Ltd.

BLRX Quotes by TradingView
  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $29.5M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email